| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.74B | 73.09B | 63.55B | 57.47B | 51.70B | 33.43B |
| Gross Profit | 28.24B | 30.53B | 25.56B | 21.66B | 17.48B | 6.17B |
| EBITDA | 12.22B | 13.98B | 11.32B | 9.31B | 8.30B | -2.56B |
| Net Income | 6.50B | 4.77B | 5.15B | 4.73B | 1.50B | -6.14B |
Balance Sheet | ||||||
| Total Assets | 135.40B | 140.14B | 111.71B | 93.15B | 87.47B | 90.90B |
| Cash, Cash Equivalents and Short-Term Investments | 23.19B | 27.99B | 21.18B | 19.00B | 21.24B | 18.07B |
| Total Debt | 76.82B | 77.72B | 59.40B | 49.21B | 47.49B | 52.87B |
| Total Liabilities | 97.40B | 100.34B | 77.68B | 65.73B | 64.39B | 70.26B |
| Stockholders Equity | 35.36B | 37.21B | 32.23B | 27.20B | 22.87B | 20.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.88B | -36.00M | -907.00M | 6.03B | -1.79B |
| Operating Cash Flow | 0.00 | 10.34B | 10.39B | 8.07B | 7.96B | -899.00M |
| Investing Cash Flow | 0.00 | -7.26B | -11.13B | -11.76B | 2.08B | -1.92B |
| Financing Cash Flow | 0.00 | 3.60B | 2.73B | 1.17B | -5.42B | -2.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥24.33B | 12.11 | ― | 3.04% | -3.47% | 14.42% | |
69 Neutral | ¥10.88B | 215.52 | ― | 5.06% | 0.36% | 81.58% | |
68 Neutral | ¥33.68B | 6.94 | 21.87% | 2.14% | 15.35% | 45.10% | |
65 Neutral | ¥7.82B | 6.22 | ― | ― | 12.19% | 28.25% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥6.41B | -24.33 | ― | 2.01% | -0.15% | -270.19% | |
54 Neutral | ¥3.90B | -3.24 | ― | ― | -4.35% | -132.57% |